When drug discovery meets brand theater
The part that sticks with me isn’t the “AI will transform medicine” flourish. It’s that Novo is doing this while it is also in the middle of a rebrand, a strategy reset, and a very public race to look more modern than Eli Lilly. That makes the Anthropic partnership feel less like a pure science story and more like a signal to investors, competitors, and maybe its own employees: we’re going to be an AI company now, or at least talk like one. I’m not dismissing the deal. If you’re running a giant
papoo.work